Clival chordoma of the nasal septum secondary to surgical pathway seeding




Abstract


Educational objective


At the conclusion of this presentation, the participants should be able to recognize seeding as a form of treatment failure in transseptal resection of clival chordomas.


Objectives


The purpose is to present a case of implanted metastases in the nasal septum after a transseptal approach for resection of clival chordoma and to compare it with other reported cases in the literature.


Study design


Case report and literature review.


Methods


The clinical history, radiologic imaging, and pathology of a single patient are reviewed.


Results


A 35-year-old female presented with a left intranasal mass that completely occluded the left nasal passage. The patient had a history of clival chordoma treated at an outside institution with multiple partial resections via a transseptal approach and postoperative Gamma Knife radiotherapy. A 2.5 cm mass in the left nasal cavity as well as a 4 cm sellar mass was identified on MRI. Biopsy of the left nasal mass confirmed the diagnosis of chordoma, which was presumed to be secondary to seeding from a previous resection attempt. The patient received no further treatment due to multiple comorbidities.


Conclusions


Recurrence of clival chordoma due to seeding along the surgical pathway is an infrequent mechanism of treatment failure, with only rare cases documented in the literature. When deciding on the appropriate surgical approach, the surgeon must consider the risk of septal seeding during a transseptal approach. The emergence of transnasal endoscopic skull base approaches may reduce the likelihood of surgical pathway tumor seeding.



Introduction


Chordomas are rare, relatively slow-growing tumors of notochordal origin that are aggressive, locally invasive, and radioresistant with a high rate of treatment failure . Although local recurrence continues to be the predominant form of treatment failure and best predictor of mortality, metastasis and recurrence along the surgical pathway are becoming more recognized, especially as stereotactic radiation becomes more common . Tumor seeding along the pathway of surgical access is an infrequent mechanism for treatment failure, with only isolated cases documented in the literature . We report seeding from a transseptal approach in a patient with both residual clival chordoma at the primary location and implanted seeded metastasis on the surgical pathway following prior partial resections and postoperative stereotactic radiotherapy. It is important for the otolaryngologist to recognize seeding of clival chordoma as a surgical complication from skull base approaches in order to choose appropriate initial management as well as to include seeding on the differential diagnosis when a mass arises in the pathway of prior surgical access.





Case presentation


A 35-year-old female presented to the University of Mississippi Medical Center Emergency Department with a 1-day history of acute onset upper and lower extremity weakness. Physical exam revealed a left hemiparesis as well as a left intranasal mass. Otolaryngology was consulted for evaluation of the nasal mass. Pertinent medical history included a clival chordoma treated at an outside hospital with multiple partial resections, most recently via a transseptal approach over 2 years prior, along with postoperative Gamma Knife radiotherapy. Outside records suggested only incomplete or subtotal resections for debulking purposes instead of intent to cure.


Nasal endoscopy revealed a gelatinous, submucosal soft tissue mass completely occluding the left nasal passage and causing mild contralateral septal deviation. The right nasal passage was unremarkable. Magnetic resonance imaging (MRI) demonstrated acute left posterior internal capsule and right lateral thalamic infarctions, as well as a 4-cm sellar mass encasing the bilateral internal carotids with partial destruction of the superior clivus, left sphenoid sinus, and left posterior ethmoid air cells. Radiology described a partially calcified heterogeneously enhancing mass compatible with known chordoma. There was an additional 2.8 × 2.5-cm T1 hypointense, T2 hyperintense heterogeneously enhancing mass in the left nasal cavity with mass effect and septal deviation. The two masses were confirmed by radiology to be separate entities without an obvious connection ( Figs. 1 and 2 ). Biopsy of the left nasal mass was performed and histopathologic examination confirmed the presence of chordoma with characteristic physalliferous cells with pale bubbly cytoplasm in a myxoid stroma ( Fig. 3 ).




Fig. 1


Axial T1-weighted MR image demonstrated a 4 cm hypointense seller mass along with a separate 2.8 × 2.5 cm hypointense mass.



Fig. 2


Sagittal T2-weighted MR image characterized a hyperintense heterogeneously enhancing mass in the left nasal cavity with mass effect and septal deviation.



Fig. 3


Histopathologic examination of the biopsy confirmed the presence of chordoma by characteristic physalliferous cells with pale bubbly cytoplasm in a myxoid stroma.


The patient was diagnosed as having chordoma recurrence following implantation in the surgical pathway and was managed nonoperatively throughout her hospital course given multiple other neurologic comorbidities. Over the following several months, she had multiple complications including severe intraventricular hemorrhage, left upper and lower extremity spasticity, and respiratory failure. At last available follow-up, the patient was discharged to a long-term acute care facility due to ventilator dependence.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 24, 2017 | Posted by in OTOLARYNGOLOGY | Comments Off on Clival chordoma of the nasal septum secondary to surgical pathway seeding

Full access? Get Clinical Tree

Get Clinical Tree app for offline access